Cybin (HELP) FCF Margin (2020 - 2024)
Cybin (HELP) posted quarterly FCF Margin of 129.18% for Q4 2024, down 91170.0% year-on-year from N/an in Q1 2024, and down 116.51% on a QoQ basis from 782.52% in Q4 2023.
Cybin (HELP) FCF Margin (2020 - 2024) Analysis & Trends
Cybin (HELP) has reported FCF Margin for 4 consecutive years, with 129.18% the latest figure, recorded in Q4 2024.
- Quarterly FCF Margin fell 91170.0% year-over-year to 129.18% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 11.02% (changed N/A YoY) and the FY2021 annual result came in at 1679219.29%, changed N/A from the prior year.
- FCF Margin slipped to 129.18% in Q4 2024 per HELP's latest filing, from 782.52% in the prior quarter.
- Over the last five years, FCF Margin for HELP reached as high as 782.52% in Q4 2023 and fell as low as 185648148.15% in Q2 2020.
- A 4-year average of 46411873.51% and a median of 64.21% in 2021 frame the typical range for FCF Margin.
- The largest YoY upside for FCF Margin was 91170 bps in 2024 against a maximum downside of 91170 bps in 2024.
- Year by year, FCF Margin stood at 185648148.15% in 2020, then surged by 100 bps to 0.76% in 2021, then soared by 102719 bps to 782.52% in 2023, then plunged by 117 bps to 129.18% in 2024.
- According to Business Quant data, FCF Margin over the past three periods registered 129.18%, 782.52%, and 0.76% for Q4 2024, Q4 2023, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -129.18% |
| Dec 31, 2023 | 782.52% |
| Mar 31, 2021 | 0.76% |
| Jun 30, 2020 | -185,648,148.15% |